INS webinars deliver the most current infusion-related topics in a 60-minute presenter-led session. Each webinar is delivered live and then archived for on-demand viewing. All webinars are free to INS members.

Webinars

Search by Format
Sort By
Search by Favorites
Search by Keyword

  • Advancing Infusion Safety Through Smart Pump EHR Interoperability
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 01/29/2026 at 1:00 PM (EST)

    This session examines how smart pump–electronic health record (EHR) interoperability improves infusion safety, accuracy, and workflow efficiency. Participants will explore how bidirectional data exchange between pumps and EHRs reduces manual programming errors and enhances clinical decision-making. The discussion will highlight key technical and clinical components that support safe, reliable integration, along with real-world outcomes demonstrating error reduction and workflow optimization. Common challenges, such as data mapping, validation, and user adoption will be addressed, with practical strategies for overcoming them. Attendees will also learn how to use interoperability data and continuous quality improvement (CQI) methods to monitor performance and drive ongoing safety improvements. By the end of the session, participants will gain a clear understanding of how to implement, sustain, and optimize interoperable infusion systems.

    image

    This session examines how smart pump–electronic health record (EHR) interoperability improves infusion safety, accuracy, and workflow efficiency. Participants will explore how bidirectional data exchange between pumps and EHRs reduces manual programming errors and enhances clinical decision-making. The discussion will highlight key technical and clinical components that support safe, reliable integration, along with real-world outcomes demonstrating error reduction and workflow optimization. Common challenges, such as data mapping, validation, and user adoption will be addressed, with practical strategies for overcoming them. Attendees will also learn how to use interoperability data and continuous quality improvement (CQI) methods to monitor performance and drive ongoing safety improvements. By the end of the session, participants will gain a clear understanding of how to implement, sustain, and optimize interoperable infusion systems.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Understand the role of smart pumps in enhancing infusion safety
    • Recognize the benefits and challenges of interoperability with clinical systems
    • Explain how smart pump EHR interoperability enhances infusion safety and workflow efficiency
    • Identify key technical and clinical components of interoperable infusion systems
    • Summarize current evidence and outcomes from interoperability implementations
    • Recognize common challenges and strategies for maintaining safe, reliable integration
    • Utilize data and CQI methods to monitor and improve interoperable infusion practices
    • Identify best practices for drug library programming and maintenance

    Sheryl Krause, PhD, RN, CEN, ACNS-BC

    Sheryl Krause, PhD, RN, CEN, ACNS-BC, worked as a bedside nurse in oncology, obstetrics, and the emergency department for 19 years before becoming a clinical nurse specialist (CNS) in the emergency department in 2005. As a CNS, Dr Krause is passionate about ensuring that nurses have access to technology that enhances patient safety without disrupting efficient and effective workflows. She completed her PhD in Nursing with a minor in Industrial and Systems Engineering in 2024. The study of human factors in health care informed her thinking about infusion therapy practices. While in the PhD program, she led a project to implement smart pump technology and interoperability. Dr Krause presented the related outcomes at the 2023 International Symposium on Human Factors and Ergonomics in Health Care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 29, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Optimizing Outcomes: Evidence-Based Approaches to Vascular Access Device Selection
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 01/28/2026 at 1:00 PM (EST)

    Selecting the appropriate vascular access device is critical when administering high-risk medications. Infusion nurses often face institutional barriers that prevent them from following evidence-based guidelines, leading to patient harm. This session provides an overview of the risks associated with incorrect device selection and introduces the INS 2024 Vesicant List as a tool for guiding safe infusion practices. Learners will explore how decision-making support tools can empower nurses to advocate for appropriate care. In this session, we will examine how clinical judgment, updated guidelines, and technology can work together to improve vascular access outcomes.

    image

    Selecting the appropriate vascular access device is critical when administering high-risk medications. Infusion nurses often face institutional barriers that prevent them from following evidence-based guidelines, leading to patient harm. This session provides an overview of the risks associated with incorrect device selection and introduces the INS 2024 Vesicant List as a tool for guiding safe infusion practices. Learners will explore how decision-making support tools can empower nurses to advocate for appropriate care. In this session, we will examine how clinical judgment, updated guidelines, and technology can work together to improve vascular access outcomes.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Review key factors that influence vascular access device (VAD) selection in clinical practice
    • Understand infusion-related considerations such as solution characteristics, administration methods, and therapy duration
    • Recognize patient and vessel-related risks associated with infusion therapy
    • Utilize educational resources to support informed, evidence-based decision-making for device selection

    Barb Nickel, APRN-CNS, CCRN, CRNI®

    Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist at a large health care system in the United States, responsible for staff development and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel has presented nationally and published in several peer-reviewed journals on infusion-related topics. She was the Chair of the 2024 INS Infusion Therapy Standards of Practice (SOP)Committee, and is now Chair of the 2027 INS SOP Committee. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 28, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Integrated vs Non-Integrated Peripheral IV Catheters: Evidence, Application, and Context in Clinical Practice
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 01/27/2026 at 4:00 PM (EST)

    Peripheral intravenous catheters (PIVCs) are among the most frequently used medical devices, yet the optimal choice between integrated and non-integrated systems is still debated. Despite strong conceptual advantages for integrated designs, real-world evidence has not consistently demonstrated superiority across all clinical contexts. This session will explore current evidence, practical implications, and cost–benefit considerations for device selection. Drawing on recent trials and clinical experience, we will discuss when integrated catheters may offer measurable benefit and when non-integrated devices may perform equally well. Participants will gain tools to interpret the evidence within the context of their own clinical environment and patient population

    image

    Peripheral intravenous catheters (PIVCs) are among the most frequently used medical devices, yet the optimal choice between integrated and non-integrated systems is still debated. Despite strong conceptual advantages for integrated designs, real-world evidence has not consistently demonstrated superiority across all clinical contexts.

    This session will explore current evidence, practical implications, and cost–benefit considerations for device selection. Drawing on recent trials and clinical experience, we will discuss when integrated catheters may offer measurable benefit and when non-integrated devices may perform equally well. Participants will gain tools to interpret the evidence within the context of their own clinical environment and patient population.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Describe the structural and functional differences between integrated and non-integrated PIVCs
    • Discuss current evidence regarding device performance, complications, and cost-effectiveness across different patient populations and care settings
    • Explain how contextual factors, such as insertion site, gauge, expected dwell time, and inserter experience affect PIVC outcomes and the applicability of published findings

    Joseph Bunch

    Tricia Kleidon, PhD, MNSc, BNSc

    Tricia Kleidon, Phd, MNSc (Nurse Practitioner), BSc (Nursing), is a Nurse Practitioner in Paediatric Vascular Assessment and Management at Queensland Children’s Hospital and a Research Fellow at The University of Queensland. She works within a dynamic clinical and research team dedicated to improving patient outcomes and reducing vascular access-related complications. Dr Kleidon recently completed her PhD, which focused on techniques and technologies to improve first-time peripheral intravenous catheter (PIVC) insertion success, and reduce complications. She is passionate about the intersection of research and clinical practice and is always up for sharing ideas—preferably over a spritz or 2.

    DJ Shannon, MPH, CIC, VA-BC, AL-CIP, FAPIC

    DJ Shannon, MPH, CIC, VA-BC, AL-CIP, FAPIC, has been involved in infection prevention and infectious diseases for over a decade, with experience spanning research, state public health, academics, and acute care hospitals. With a background in human biology and epidemiology, his focus is on the intersection of antimicrobial resistance, device-associated infections, and infection prevention. Mr Shannon is the 2025 Immediate Past President of Association for Professionals in Infection Control and Epidemiology (APIC) Indiana. He was a clinical reviewer for the 2021 INS Infusion Therapy Standards of Practice and a co-author of the Association for Vascular Access (AVA) Standards of Care for Peripheral Intravenous Catheters. Most recently, he served as the lead author for the APIC Implementation Guide for Preventing Catheter-Associated Bloodstream Infections (CABSIs) in Adults.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 27, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Immediate-Use Compounding
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 12/10/2025 at 1:00 PM (EST)

    As health-care professionals, we are entrusted with making sure that every compounded sterile preparation (CSP) is accurate and carries the lowest possible risk of contamination. It is preferred that CSPs are prepared in a pharmacy’s ISO-5 compounding suite. However, there are occasions when patient needs require us to prepare medications outside of those controlled settings. This course will take an in-depth look at the minimum requirements as well as the best practices for maintaining patient safety when sterile drugs are mixed in environments outside of a cleanroom.

    As health-care professionals, we are entrusted with making sure that every compounded sterile preparation (CSP) is accurate and carries the lowest possible risk of contamination. It is preferred that CSPs are prepared in a pharmacy’s ISO-5 compounding suite. However, there are occasions when patient needs require us to prepare medications outside of those controlled settings. This course will take an in-depth look at the minimum requirements as well as the best practices for maintaining patient safety when sterile drugs are mixed in environments outside of a cleanroom. 

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Define immediate-use compounding under USP <797> (2023)
    • Identify and understand the seven criteria that qualify preparation as an immediate-use CSP, exempting it from full USP <797> requirements
    • Describe best practices for reducing the risk of contamination when compounding for immediate use outside of ISO-5 conditions
    • Explain the distinction between compounding and preparation by approved labeling

    Maegan Brehm, PharmD

    Maegan Brehm, PharmD, is a Clinical Operations Pharmacist with WeInfuse and RxToolKit, where she promotes clinical safety initiatives. Dr Brehm graduated from the University of Nebraska Medical Center and began her career managing a high-volume retail pharmacy. She then transitioned to sterile compounding and home infusion care at Option Care Health and later to a critical access hospital in Nebraska. Her current work includes developing clinical competencies and RxWorkflow tools through RxToolKit and providing expert advice and real-world insight to the WeInfuse software engineering team. Dr Brehm brings over 12 years of experience in infusion therapy, sterile compounding, and staff education. She has a passion for improving patient safety, mentoring learners, and translating complex standards into practical solutions.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: December 10, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Novel Antibiotics: Niches, Efficacies, and Clinical Pearls
    Contains 3 Component(s), Includes Credits Recorded On: 11/12/2025

    Antibiotic resistance is of growing concern to the medical community and is associated with substantial morbidity and mortality. Accordingly, beginning in 2012, the United States federal government incentivized the development of new antibiotics. A variety of new antimicrobials have been approved over the last decade that are becoming routinely used in clinical practice. In this session, we will address the clinical data supporting the use of these antibiotics in specific clinical scenarios and identify clinical pearls germane to the infusion nurse.

    Antibiotic resistance is of growing concern to the medical community and is associated with substantial morbidity and mortality. Accordingly, beginning in 2012, the United States federal government incentivized the development of new antibiotics. A variety of new antimicrobials have been approved over the last decade that are becoming routinely used in clinical practice. In this session, we will address the clinical data supporting the use of these antibiotics in specific clinical scenarios and identify clinical pearls germane to the infusion nurse.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Describe the current landscape of antimicrobial development, approval, and use within the United States
    • Explain mechanisms of antimicrobial resistance
    • Identify newly approved antibiotics and their role in clinical care
    • Appropriately monitor a patient receiving a novel antibiotic for therapeutic appropriateness and clinical success

    Herman Johannesmeyer, PharmD, BCPS

    Herman Johannesmeyer, PharmD, BCPS, received his Doctor of Pharmacy degree from the University of Arizona in Tucson, Arizona and completed a 2-year pharmacotherapy residency at Texas Tech University Health Sciences Center in Lubbock, Texas. Dr Johannesmeyer provides didactic instruction in the University of California, Irvine School of Pharmacy and Pharmaceutical Sciences Doctor of Pharmacy curriculum within the renal and gastrointestinal pharmacotherapy courses. At the UC Irvine Medical Center, Dr Johannesmeyer works as a rounding internal medicine pharmacist, working with hospital medicine physician teams to provide optimal pharmacotherapeutic treatment plans for admitted floor-status inpatients. His research interests include corticosteroid stewardship, antibiotic stewardship, and inpatient glycemic control.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: November 12, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.